Table 1.
Applied methods and targeted analytes for the detection of COVID-19.
Methods | Analyte | Detection time | Sensitivity | Accuracy | DOL | Advantages | Reference |
---|---|---|---|---|---|---|---|
RT-PCR | RNA | 75 min | – | – | 10 copies/reaction | Specific | [56] |
PCR | DNA | – | 91% | 93% | 2 copies/reaction | specific | [60] |
RT-PCR | C2CA | 100 min | 100% | 0.4 fM | specific | [62] | |
ELISA | IgG/IgM | – | 89.6% | – | – | Portable, fast | [29] |
ELISA | IgG/IgM | 30 min | 85.4% | 98.6% | 1 copies/μL | Portable, fast | [66] |
MS | DNA | 3 h | – | – | 105 copies | specific | [69] |
MS | DNA | 24–48 h | – | – | 155–106 copies/μL | Specific | [71] |
CLIA | IgG/IgM | – | – | 81.5% | – | Fast, portable | [74] |
CLIA | DNA | – | 100% | 87% | – | Specific, fast, portable | [75] |
LFIA | IgG/IgM | – | – | – | 1 × 104 Pfu | Sensitive | [83] |
LFIA | IgG/IgM | – | 100% | – | – | sensitive | [26] |
LAMP | DNA | – | 97.6% | – | 0.2–47 ng/μL | Specific, portable | [94] |
LSPR | IgG/IgM | 2 h | – | – | 0.08 ng/mL | sensitive | [103] |
LSPR | RNA | – | 3.2 copies | – | 0.22 pM | Specific, sensitive | [104] |
FET | antibody | – | – | – | 16 Pfu/μL | Specific, sensitive | [107] |
electrochemical | DNA | – | – | – | 200 copies/mL | Sensitive, fast, portable, specific | [101] |
electrochemical | IgG/IgM | – | 100% | – | 1 ng/mL | Sensitive, fast | [131] |
electrochemical | IgG/IgM | – | 0.0048 μAμgmL−1cm−2 | – | 1.68 × 10−22 μg/mL | Sensitive, fast | [132] |
electrochemical | IgG/IgM | – | – | – | 19 ng/mL | Sensitive, fast, portable | [134] |